Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Accentia Biopharmaceuticals Inc (ABPI) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Accentia Biopharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1310094.
Total stock buying since 2010: $223,694.
Total stock sales since 2010: $100,000.
Total stock option exercises since 2010: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2011 | 0 | $0 | 500,000 | $100,000 | 0 | $0 |
| 2010 | 225,954 | $223,694 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2011-12 | 0 | $0 | 500,000 | $100,000 | 0 | $0 |
| 2010-11 | 225,954 | $223,694 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-12-23 | Odonnell Francis E Jr (Executive Chairman) | Sale | 500,000 | .20 | 100,000 |
| 2010-11-24 | Odonnell Francis E Jr (CHAIRMAN & CEO) | Buy | 225,954 | .99 | 223,694 |
Insider trading activities including stock purchases, stock sales, and option exercises of ABPI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Accentia Biopharmaceuticals Inc (symbol ABPI, CIK number 1310094) see the Securities and Exchange Commission (SEC) website.